Aug 07, 2024
You're invited to this special broker webinar where Kaiser Permanente takes a closer look at GLP-1 drugs, often used for weight loss and diabetes. They'll explore the impact these medications are having for consumers, the cost pressures they're driving, and how an evidence-based approach is key to unlocking their full potential.
- Hear how Kaiser Permanente helps members work toward a healthy weight with personalized and evidence-based care for their physical, mental, and social health
- Gain insights into the relationship between GLP-1s and various comorbidities that can accompany obesity
- Gain expertise in navigating the complexities of employer conversations around chronic conditions and the high cost of weight-loss drugs
- Get your questions answered during a live Q&A
In addition, you’ll learn about the latest market insights and product announcements from Kaiser Permanente.
When: Tuesday, August 20th from 11 a.m. - 12 noon (PST) 2 p.m. - 3 p.m. (EST)
Claim your spot to join the conversation.
Host: John Rott, MD, Kaiser Permanente
Guest Speaker: Sean Hashmi, MD, MS, FASN, Regional Director for Lifestyle and Obesity Medicine, Southern California Permanente Medical Group, Kaiser Permanente
“Kaiser,” “Kaiser Permanente,” “Kaiser Foundation Health Plan” and the Kaiser Permanente Logo are registered trademarks or service marks of Kaiser Foundation Health Plan, Inc., in the United States.
Feel free to contact your Amwins Connect Sales Representative for more information.
